Arun Upadhyay - Jan 2, 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Scientific Officer, Head of Research, Development and Medical
Signature
/s/ Arun Upadhyay by Shankar Musunuri, his attorney-in-fact
Stock symbol
OCGN
Transactions as of
Jan 2, 2025
Transactions value $
-$37,241
Form type
4
Date filed
1/6/2025, 05:02 PM
Previous filing
Sep 26, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Tax liability -$37.2K -41.6K -11.97% $0.89 306K Jan 3, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +731K $0.00 731K Jan 2, 2025 Common Stock 731K $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.

Remarks:

Chief Scientific Officer, Head of Research, Development and Medical